Suppr超能文献

裸质粒DNA基因疫苗:CTL启动机制

Gene vaccination with naked plasmid DNA: mechanism of CTL priming.

作者信息

Corr M, Lee D J, Carson D A, Tighe H

机构信息

Department of Medicine, University of California, San Diego, La Jolla 92093-0663, USA.

出版信息

J Exp Med. 1996 Oct 1;184(4):1555-60. doi: 10.1084/jem.184.4.1555.

Abstract

The injection of naked plasmid DNA directly into the muscle cells of mice has been shown to induce potent humoral and cellular immune responses. The generation of a cytotoxic T lymphocyte (CTL) response after plasmid DNA injection may involve the presentation of the expressed antigen in the context of the injected myocytes' endogenous major histocompatibility (MHC)-encoded class I molecules or may use the MHC molecules of bone marrow-derived antigen presenting cells (APC) which are capable of providing co-stimulation as well. To resolve which cell type provides the specific restricting element for this method of vaccination we generated parent-->F1 bone marrow chimeras in which H-2bxd recipient mice received bone marrow that expressed only H-2b or H-2d MHC molecules. These mice were injected intramuscularly with naked plasmid DNA that encoded the nucleoprotein from the A/PR/8/34 influenza strain, which as a single antigen has epitopes for both H-2Db and H-2Kd. The resulting CTL responses were restricted to the MHC haplotype of the bone marrow alone and not to the second haplotype expressed by the recipient's myocytes. The role of somatic tissues that express protein from injected plasmids may be to serve as a reservoir for that antigen which is then transferred to the APC. Consequently, our data show that the mechanism of priming in this novel method for vaccination uses the MHC from bone marrow-derived APC, which are efficient at providing all of the necessary signals for priming the T cell.

摘要

已证明将裸露的质粒DNA直接注射到小鼠的肌肉细胞中可诱导强烈的体液免疫和细胞免疫反应。注射质粒DNA后细胞毒性T淋巴细胞(CTL)反应的产生可能涉及在注射的肌细胞内源性主要组织相容性(MHC)编码的I类分子的背景下呈递表达的抗原,或者可能利用骨髓来源的抗原呈递细胞(APC)的MHC分子,这些细胞也能够提供共刺激。为了确定哪种细胞类型为这种疫苗接种方法提供特异性限制元件,我们构建了亲代→F1骨髓嵌合体,其中H-2bxd受体小鼠接受仅表达H-2b或H-2d MHC分子的骨髓。这些小鼠肌肉注射编码来自A/PR/8/34流感病毒株核蛋白的裸露质粒DNA,该核蛋白作为单一抗原具有针对H-2Db和H-2Kd的表位。产生的CTL反应仅受限于骨髓的MHC单倍型,而不受受体肌细胞表达的第二种单倍型的限制。表达来自注射质粒的蛋白质的体细胞组织的作用可能是作为该抗原的储存库,然后该抗原被转移到APC。因此,我们的数据表明,这种新型疫苗接种方法中的启动机制使用来自骨髓来源的APC的MHC,其能够有效地提供启动T细胞所需的所有信号。

相似文献

引用本文的文献

2
Pathways of MHC I cross-presentation of exogenous antigens.MHC I 类分子交叉呈递外源抗原的途径。
Semin Immunol. 2023 Mar;66:101729. doi: 10.1016/j.smim.2023.101729. Epub 2023 Feb 16.
4
Nucleic acid-based therapy for coronavirus disease 2019.2019冠状病毒病的核酸疗法
Heliyon. 2020 Sep;6(9):e05007. doi: 10.1016/j.heliyon.2020.e05007. Epub 2020 Sep 19.
7
New Vaccine Technologies to Combat Outbreak Situations.新型疫苗技术应对疫情爆发。
Front Immunol. 2018 Sep 19;9:1963. doi: 10.3389/fimmu.2018.01963. eCollection 2018.

本文引用的文献

7
The transporters associated with antigen presentation.与抗原呈递相关的转运蛋白。
Semin Cell Biol. 1993 Feb;4(1):53-61. doi: 10.1006/scel.1993.1007.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验